Results 281 to 290 of about 144,950 (353)

Clinical Characteristics in Swedish Children With and Without Autoantibodies at the Time of Type 1 Diabetes Diagnosis. [PDF]

open access: yesDiabetes Care
Hedlund E   +9 more
europepmc   +1 more source

Forsythiaside A Alleviates Kidney Injury and Intestinal Epithelium Dysfunction in IgA Nephropathy by Inhibiting TLR4/NF‐κB Signaling

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT IgA nephropathy (IgAN), the most common form of glomerulonephritis, is a major and growing public health issue. It results from intestinal barrier dysfunction that leads to mesangial deposition of pathogenic galactose‐deficient IgA1 (Gd‐IgA1) and renal inflammation.
Meng‐Si Li, Kai Liu
wiley   +1 more source

Proteomics of Nitrotyrosine: Integrating Mass Spectrometry and Immunodetection in Redox‐Driven Pathology

open access: yesMass Spectrometry Reviews, EarlyView.
ABSTRACT Nitrooxidative stress, driven by excess reactive nitrogen species like peroxynitrite, contributes to the pathogenesis of many chronic diseases. Among its molecular footprints, 3‐nitrotyrosine (3NT) has emerged as a biologically relevant marker of protein nitration.
Brîndușa Alina Petre
wiley   +1 more source

Autoantibodies as predictors of progression to rheumatoid arthritis: a systematic review and meta-analysis. [PDF]

open access: yesRMD Open
Qureshi S   +28 more
europepmc   +1 more source

Association of G-Protein-Coupled Receptors autoantibodies with vasoregulation in Post-COVID. [PDF]

open access: yesPLoS One
Seibert FS   +9 more
europepmc   +1 more source

Autoantibodies

open access: yesAutoimmunity, 1995
openaire   +1 more source

Combined FXIII-C3 autoantibodies elicit bleeding and complement dysfunction in autoimmune FXIII deficiency. [PDF]

open access: yesJ Clin Invest
Luo S   +26 more
europepmc   +1 more source

Endothelial Biomarkers and Cytokine Profiles: Signatures of Mortality in Severe COVID-19. [PDF]

open access: yesInt J Mol Sci
van Staden QA   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy